SOURCE: eLocity Inc.

June 29, 2005 07:10 ET

Wednesday's June 29th Stock Trading Alert

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by eLocity.

SARASOTA, FL -- (MARKET WIRE) -- June 29, 2005 -- eLocity's stocks to watch for Wednesday are -- Xpention Genetics, Inc. (OTC BB: XPNG), GeneThera, Inc. (OTC BB: GTHA), HealthSouth Corp. (OTC: HLSH), Abgenix, Inc. (NASDAQ: ABGX)

Investors, have a look at Xpention Genetics, Inc. (OTC BB: XPNG), a biotechnology company that was formed to develop both immunological and molecular tests for cancer detection in animals and humans, as well as therapeutic vaccines and other treatment methods for companion animal cancers. The company announced Tuesday that it has contracted GeneThera, Inc. (OTC BB: GTHA), a molecular biotechnology company which provides genetic diagnostic solutions for the veterinary, agricultural, and health-care industries, to develop a molecular diagnostic cancer test for use on canines.

The cancer test will use Xpention's licensed p65 technology from the University of Texas MD Anderson Cancer Center, a promising marker for the early detection of malignant tumor formation and a useful tool for monitoring therapy and remission, the company said. Levels of p65 also appear to have a direct correlation to tumor mass/size, Xpention noted.

Xpention Genetics explained that in addition to the immunological test which gives a yes or no result, a molecular test will be able to measure the level of expression of the p65 protein allowing its use as a confirmatory test and enabling doctors to determine the effectiveness of treatments.

Shares of Xpention Genetics, Inc. (OTC BB: XPNG) are currently trading at around 82 cents.

Other stocks to watch:

HealthSouth Corp. (OTC: HLSH)

HealthSouth Corp. announced Tuesday that jurors have acquitted the company's founder and Ex-Chief Executive Officer, Richard Scrushy, of all charges relating to a $2.7 billion earnings overstatement at a medical rehabilitation chain Scrushy founded. The company said that the outcome of the trial has no direct impact on HealthSouth and that the company will move forward with a new Board of Directors, leadership team, governance programs and new focus on its core businesses.

HLSH.PK closed Tuesday's regular trading session at $5.93

Abgenix, Inc. (NASDAQ: ABGX)

Biopharmaceutical company Abgenix, Inc. announced Tuesday that it will consolidate its research and preclinical studies at its facility in Canada, thus resulting in a reduction of approximately 15 percent of the company's work force. Abgenix said it is currently developing a promising cancer treatment with Amgen Inc., and will continue to conduct other operations at company headquarters in California.

ABGX closed Tuesday's regular trading session at $15.89. AMGN closed the session at $61.79.

About eLocity Inc: eLocity owns and operates three financial websites for investors.

-PennyPicks.com, http://www.pennypicks.com/. Featuring active message boards for the penny stock trader, rumors and more.

-StockGrid.com, http://www.stockgrid.com/. Visit this site for our daily top stock "GRID Makers." We rank stocks on volume, message board activity, sentiment and trend forecast.

-Bell2Bell.com, http://www.bell2bell.com/. Bell2Bell features news stories, rumors, the InvestBoard and more.

Sign up for FREE at any of the sites above.

The newsletter is provided by eLocity Inc., an electronic broadcaster and publisher of this newsletter, is here after referred to as "the company." The company received compensation for newsletter and ad services for XPNG. (Public Company). The compensation is one thousand dollars. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The company reserves the right to trade in securities mentioned herein, and may make purchases or sales in such securities featured within our newsletter reports. The information contained in this publication is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. All statements of opinions, if any, (Our Summary) are those of the company.

The company relies exclusively on information gathered on the Public Company, such as public filings, press releases and its web sites. Investors should use the information contained in this publication as a starting point for conducting additional research on the Public Company in order to allow the investor to form his or her own opinion regarding the Public Company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the Public Company that this newsletter is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment made in the client. This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended.

The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information

  • Contact:
    eLocity Inc.
    941-544-3498
    Thomas Clay